SCHEMBL4028517

SCHEMBL4028517

COC(=O)c1cccc(C(=O)N(C)C)c1NC(=O)OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.46
MGLL Q99685 1/20 0.45
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 2/20 0.44
GAA P10253 1/20 0.44
POLB P06746 1/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2C19 P33261 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
TSHR P16473 1/20 0.44
HSD17B10 Q99714 1/20 0.44
LMNA P02545 1/20 0.44
KAT2B Q92831 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10874779 0.79 NPC1 (0.68) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E
SCHEMBL10192674 0.76 NPC1 (0.64) CASP3NPC1RAB9ASMN1; SMN2MGLL
SCHEMBL2529867 0.75 KDM4E (0.56) NPC1RAB9AMGLLALDH1A1KDM4E
SCHEMBL4650207 0.74 NPC1 (0.58) CASP3NPC1RAB9ASMN1; SMN2MGLL
SCHEMBL3820448 0.74 ALDH1A1 (0.74) CASP3RAB9AALDH1A1KDM4EGAA
SCHEMBL7659684 0.74 CASP3 (0.46) CASP3NPC1RAB9ASMN1; SMN2MGLL
SCHEMBL10192673 0.73 NPC1 (0.56) CASP3NPC1RAB9ASMN1; SMN2MGLL
SCHEMBL6929631 0.73 NPC1 (0.63) CASP3NPC1RAB9ASMN1; SMN2MGLL
SCHEMBL5241284 0.72 RAB9A (0.55) CASP3NPC1RAB9ASMN1; SMN2MGLL
SCHEMBL5056843 0.72 CYP2C19 (0.60) NPC1RAB9ASMN1; SMN2MGLLALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046761-A2 MACROCYCLIC COMPOUNDS USEFUL AS BACE INHIBITORS Novartis AG (CH) 2009-04-15 EP disclosed
WO-2008009750-A2 MACROCYCLIC COMPOUNDS USEFUL AS BACE INHIBITORS NOVARTIS AG (CH) 2008-01-24 WO disclosed